Susquehanna International Group
IMGN

Susquehanna International Group’s Immunogen Inc IMGN Stock Holding History

Susquehanna International Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-486,000
Closed -$14.4M – 13803
2023
Q4 		$14.4M Sell
486,000
-33,500
-6% -$667K ﹤0.01% 2170
2023
Q3 		$8.24M Buy
519,500
+162,800
+46% +$2.71M ﹤0.01% 2804
2023
Q2 		$6.73M Sell
356,700
-103,100
-22% -$1.22M ﹤0.01% 3056
2023
Q1 		$1.77M Buy
459,800
+183,500
+66% +$782K ﹤0.01% 5419
2022
Q4 		$1.37M Buy
276,300
+198,500
+255% +$1.08M ﹤0.01% 5482
2022
Q3 		$372K Buy
77,800
+34,200
+78% +$180K ﹤0.01% 9258
2022
Q2 		$196K Sell
43,600
-83,600
-66% -$363K ﹤0.01% 10665
2022
Q1 		$605K Buy
127,200
+500
+0.4% +$2.77K ﹤0.01% 8471
2021
Q4 		$940K Sell
126,700
-168,900
-57% -$1.05M ﹤0.01% 7473
2021
Q3 		$1.68M Buy
295,600
+257,300
+672% +$1.49M ﹤0.01% 6222
2021
Q2 		$252K Sell
38,300
-19,900
-34% -$139K ﹤0.01% 11134
2021
Q1 		$471K Sell
58,200
-156,500
-73% -$1.28M ﹤0.01% 9623
2020
Q4 		$1.39M Buy
214,700
+115,300
+116% +$672K ﹤0.01% 5923
2020
Q3 		$358K Buy
99,400
+18,300
+23% +$73.9K ﹤0.01% 8353
2020
Q2 		$373K Buy
81,100
+3,600
+5% +$15.3K ﹤0.01% 7953
2020
Q1 		$264K Buy
77,500
+700
+0.9% +$3.06K ﹤0.01% 8215
2019
Q4 		$392K Buy
76,800
+16,400
+27% +$55.7K ﹤0.01% 7469
2019
Q3 		$146K Sell
60,400
-89,900
-60% -$239K ﹤0.01% 9342
2019
Q2 		$326K Sell
150,300
-639,400
-81% -$1.51M ﹤0.01% 8143
2019
Q1 		$2.14M Buy
789,700
+723,500
+1,093% +$3.13M ﹤0.01% 3639
2018
Q4 		$318K Sell
66,200
-37,100
-36% -$225K ﹤0.01% 6889
2018
Q3 		$978K Sell
103,300
-255,900
-71% -$2.46M ﹤0.01% 5256
2018
Q2 		$3.5M Sell
359,200
-44,100
-11% -$465K ﹤0.01% 3179
2018
Q1 		$4.24M Buy
403,300
+224,700
+126% +$2.22M ﹤0.01% 2747
2017
Q4 		$1.15M Sell
178,600
-84,800
-32% -$523K ﹤0.01% 4958
2017
Q3 		$2.02M Buy
263,400
+145,200
+123% +$965K ﹤0.01% 3896
2017
Q2 		$840K Sell
118,200
-57,200
-33% -$262K ﹤0.01% 5634
2017
Q1 		$679K Sell
175,400
-46,800
-21% -$137K ﹤0.01% 5933
2016
Q4 		$453K Buy
222,200
+94,100
+73% +$189K ﹤0.01% 7205
2016
Q3 		$343K Buy
128,100
+40,600
+46% +$118K ﹤0.01% 6712
2016
Q2 		$270K Buy
87,500
+13,600
+18% +$85.3K ﹤0.01% 7127
2016
Q1 		$630K Sell
73,900
-41,200
-36% -$349K ﹤0.01% 5987
2015
Q4 		$1.56M Sell
115,100
-63,200
-35% -$778K ﹤0.01% 4546
2015
Q3 		$1.71M Buy
178,300
+51,300
+40% +$750K ﹤0.01% 4589
2015
Q2 		$1.83M Buy
127,000
+6,700
+6% +$73.6K ﹤0.01% 4920
2015
Q1 		$1.08M Sell
120,300
-30,000
-20% -$217K ﹤0.01% 5613
2014
Q4 		$917K Buy
150,300
+48,500
+48% +$444K ﹤0.01% 6045
2014
Q3 		$1.08M Sell
101,800
-32,500
-24% -$368K ﹤0.01% 5780
2014
Q2 		$1.59M Sell
134,300
-51,600
-28% -$648K ﹤0.01% 5096
2014
Q1 		$2.77M Sell
185,900
-120,900
-39% -$1.91M ﹤0.01% 3776
2013
Q4 		$4.5M Sell
306,800
-26,800
-8% -$412K ﹤0.01% 3101
2013
Q3 		$5.68M Buy
333,600
+121,900
+58% +$2.14M ﹤0.01% 2546
2013
Q2 		$3.51M Buy
+211,700
New +$3.43M ﹤0.01% 3073

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's IMGN Position: Q1 2024 in Review

Susquehanna International Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 736,034 shares — an estimated $21.8M sold.

Susquehanna International Group first reported a position in IMGN in Q2 2013 and held it in 37 quarters. The position peaked at $24.8M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Susquehanna International Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 736,034 Immunogen Inc shares in Q1 2024, an estimated $21.8M.
  • Susquehanna International Group first reported a position in Immunogen Inc in Q2 2013 and held it in 37 quarters.
  • Susquehanna International Group's Immunogen Inc position peaked at $24.8M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.